Should I buy or sell Tilray Inc (TLRY)?
Shares of Tilray soared yesterday on a surprise profit. Still, the stock is down 89% from its 1-year high. Read why it's a good time to sell TLRY stock.
Will Tilray’s stock gain 5 days in a row?
Apr 05, 2022 · The Tilray Inc. stock price fell by -5.65% on the last day (Tuesday, 5th Apr 2022) from $7.45 to $7.03. and has now fallen 6 days in a row.During the day the stock fluctuated 8.54% from a day low at $6.91 to a day high of $7.50.The price has fallen in 6 of the last 10 days, but is still up by 23.77% over the past 2 weeks. Volume has increased on the last day by 6 million …
How is the stock rating of Tilray calculated?
Dec 15, 2021 · Should You Sell Tilray Inc (TLRY) Stock Wednesday Morning? Wednesday, December 15, 2021 09:02 AM | InvestorsObserver Analysts Tilray Inc ( TLRY ) is higher by Wednesday morning, with the stock climbing 0.62% in pre-market trading to 8.1.
What happened to Tilray Cl 2 stock?
Apr 05, 2022 · Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Is Tilray Inc. worth watching? 2 stock analysts on Stockchase covered Tilray Inc. In the last year. It is a trending stock that is worth watching. What is Tilray Inc ...
Is Tilray a hold or sell?
Tilray has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 5 buy ratings, 7 hold ratings, and 1 sell rating.
Is Tilray stock expected to rise?
Stock Price Forecast The 16 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 8.00, with a high estimate of 23.00 and a low estimate of 5.50. The median estimate represents a +28.41% increase from the last price of 6.23.
Is TLRY stock a good buy?
Shares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now. IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.
What is the future of Tilray stock?
The analysts following Tilray expect it to perhaps double its 2021 revenues in fiscal 2022. That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue.Jan 4, 2022
Is Tilray a buy Zacks?
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return4Sell5.61%5Strong Sell2.64%S&P50011.20%3 more rows
Will Tilray stock go up tomorrow?
Tomorrow's movement Prediction of Tilray, Inc. TLRY as on 08 Apr 2022 appears undecisive. It can be Bearish or Bullish. You should wait for the first half to take a decision on this stock....Munafa value: 44 as on 08 Fri Apr 2022.Downside target5.95Upside target6.76Upside target6.93Upside target7.396 more rows
Why is Tilray dropping?
Tilray ( TLRY -2.20% ) shareholders lost ground to the market in December, with the stock slumping 31% compared to a 4% spike in the S&P 500, according to data provided by S&P Global Market Intelligence. The drop came as investors moved away from the marijuana space after pouring into the sector through much of 2021.Jan 5, 2022
Why is TLRY stock down today?
Shares of Tilray were down after the company reported a wider-than-expected net loss in the fourth quarter despite a beat in revenue.
What is Tilray Inc. stock symbol?
Tilray Inc. is a American stock, trading under the symbol TLRY-Q on the NASDAQ (undefined). It is usually referred to as NASDAQ:TLRY or TLRY-Q
Is Tilray Inc. a buy or a sell?
In the last year, 2 stock analysts published opinions about TLRY-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock...
Is Tilray Inc. a good investment or a top pick?
Tilray Inc. was recommended as a Top Pick by null on null. Read the latest stock experts ratings for Tilray Inc..
Why is Tilray Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should b...
Is Tilray Inc. worth watching?
2 stock analysts on Stockchase covered Tilray Inc. In the last year. It is a trending stock that is worth watching.
What is Tilray Inc. stock price?
On 2022-03-18, Tilray Inc. (TLRY-Q) stock closed at a price of $5.5.
Is Tilray Brands Stock a good buy in 2022, according to Wall Street analysts?
The consensus among 6 Wall Street analysts covering ( NASDAQ : TLRY ) stock is to Hold TLRY stock. Out of 6 analysts , 2 ( 33.33% ) are r...
What is TLRY's earnings growth forecast for 2022-2024?
( NASDAQ : TLRY ) Tilray Brands 's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty...
What is TLRY's revenue growth forecast for 2022-2024?
( NASDAQ : TLRY ) Tilray Brands 's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty...
What is TLRY's forecast return on assets (ROA) for 2022-2025?
(NASDAQ: TLRY) forecast ROA is 3.48%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 16.62%.
What is TLRY's Price Target?
According to 6 Wall Street analyst s that have issued a 1 year TLRY price target, the average TLRY price target is $11.15 , with the highes...
What is TLRY's Earnings Per Share (EPS) forecast for 2022-2024?
(NASDAQ: TLRY) Tilray Brands's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that TLRY's EPS will be -$0.23 for 2022, with...
What is TLRY's forecast return on equity (ROE) for 2022-2025?
(NASDAQ: TLRY) forecast ROE is 4.52%, which is considered weak.
Signals & Forecast
There are mixed signals in the stock today. The Tilray Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Support, Risk & Stop-loss
Tilray Inc. finds support from accumulated volume at $13.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Tilray Inc. stock A Buy?
Tilray Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Where is Tilray located?
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Nanaimo, British Columbia. Tilray also has operations in Australia & New Zealand, Germany, Portugal, and Latin America. Y!
What does a high score mean for tilray?
Stockchase rating for Tilray Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
TLRY earnings per share forecast
What is TLRY 's earnings per share in the next 3 years based on estimates from 9 analysts?
TLRY revenue forecast
What is TLRY 's revenue in the next 3 years based on estimates from 6 analysts?
TLRY revenue growth forecast
How is TLRY forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Tilray, Inc. (TLRY)
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Style Scorecard
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
Chart for TLRY
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.
Recently Viewed Tickers
Visit a quote page and your recently viewed tickers will be displayed here.
Tilray Inc. Cl 2
Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts.